Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults

Journal of the American College of Cardiology

Volumn 67, Issue 2, 2016, Pages 230-231

  Millwood, Iona Y ^b   Bennett, Derrick A ^b   Walters, Robin G ^b   Clarke, Robert ^b   Waterworth, Dawn ^b   Johnson, Toby ^b   Chen, Yiping ^b   Yang, Ling ^b   Guo, Yu ^b   Bian, Zheng ^b   Hacker, Alex ^b   Yeo, Astrid ^b   Parish, Sarah ^b   Hill, Michael R ^b   Chissoe, Stephanie ^b   Peto, Richard ^b   Cardon, Lon ^b   Collins, Rory ^b   Li, Liming ^b   Chen, Zhengming ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DARAPLADIB; PHOSPHOLIPASE A2; 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BENZALDEHYDE DERIVATIVE; OXIME; PHOSPHOLIPASE A2 INHIBITOR;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINESE; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LOSS OF FUNCTION MUTATION; PHASE 3 CLINICAL TRIAL (TOPIC); PLA2G7 GENE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; TRANSIENT ISCHEMIC ATTACK; ARTERIAL OCCLUSIVE DISEASES; CHINA; COMPLICATION; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; MIDDLE AGED; STROKE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ARTERIAL OCCLUSIVE DISEASES; BENZALDEHYDES; CHINA; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OXIMES; PHOSPHOLIPASE A2 INHIBITORS; STROKE;

EID: 84959306180     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.056     Document Type: Letter

References (5)

1. H.D. White, C. Held, R. Stewart, and et al. Darapladib for preventing ischemic events in stable coronary heart disease N Engl J Med 370 2014 1702 1711
2. M.L. O'Donoghue, E. Braunwald, H.D. White, and et al. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial JAMA 312 2014 1006 1015
3. Q. Wang, Y. Hao, X. Mo, and et al. PLA2G7 gene polymorphisms and coronary heart disease risk: a meta-analysis Thromb Res 126 2010 498 503
4. D.M. Evans, and G. Davey Smith Mendelian randomization: new applications in the coming age of hypothesis-free causality Annu Rev Genomics Hum Genet 16 2015 327 350
5. Z. Chen, J. Chen, R. Collins, and et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up Int J Epidemiol 40 2011 1652 1666